Follow the Apimeds Pharmaceuticals US, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €6.4m. The latest transaction was disclosed on 11 June 2025 (C). Among the most active insiders: Inscobee Inc.. All data is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€2m
3 ops.
Buy Volume
n/a
n/a
Sell Volume
38Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.